Northland Securities Expects Higher Earnings for Astera Labs

Astera Labs, Inc. (NASDAQ:ALAB) – Analysts at Northland Securities boosted their Q3 2026 earnings per share estimates for shares of Astera Labs in a research report issued to clients and investors on Wednesday, August 5th. Northland Securities analyst G. Richard now expects that the company will earn $0.83 per share for the quarter, up from their prior estimate of $0.47. Northland Securities currently has a “Market Perform” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $1.86 per share. Northland Securities also issued estimates for Astera Labs’ Q4 2026 earnings at $1.09 EPS, FY2026 earnings at $2.75 EPS, Q1 2027 earnings at $1.13 EPS, Q2 2027 earnings at $1.32 EPS, Q3 2027 earnings at $1.44 EPS, Q4 2027 earnings at $1.55 EPS and FY2027 earnings at $5.43 EPS.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS.

ALAB has been the subject of a number of other reports. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price for the company. JPMorgan Chase & Co. upped their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. UBS Group reiterated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Susquehanna lifted their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Needham & Company LLC upped their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $325.25.

Astera Labs Stock Performance

Shares of ALAB stock opened at $311.99 on Wednesday. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a 50-day simple moving average of $359.51 and a two-hundred day simple moving average of $237.55. The company has a market capitalization of $54.13 billion, a price-to-earnings ratio of 154.45 and a beta of 3.84.

Hedge Funds Weigh In On Astera Labs

Large investors have recently made changes to their positions in the business. Royal Bank of Canada lifted its position in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares in the last quarter. AQR Capital Management LLC lifted its position in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the period. First Trust Advisors LP boosted its position in shares of Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its holdings in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total transaction of $270,997.44. Following the transaction, the director directly owned 5,550 shares of the company’s stock, valued at $2,192,472. This represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the sale, the director directly owned 53,961 shares in the company, valued at approximately $16,826,658.63. The trade was a 6.10% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,256,894 shares of company stock worth $362,763,135. Corporate insiders own 10.40% of the company’s stock.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities sharply raised its earnings forecasts. The firm increased its FY2026 EPS estimate to $2.75 from $1.82 and its FY2027 estimate to $5.43 from $2.26. Quarterly estimates were also lifted, including Q3 2026 EPS to $0.83 from $0.47 and Q4 2026 EPS to $1.09 from $0.56. The revisions imply stronger expected growth in Astera Labs’ AI connectivity business and are well above the current-year consensus estimate of $1.86 per share.
• Positive Sentiment: AMD’s Helios AI systems could benefit Astera Labs. Analysts expect AMD’s rack-scale AI systems to ramp, potentially creating additional demand for Astera Labs’ connectivity products alongside other ecosystem partners. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Neutral Sentiment: Northland maintained a “Market Perform” rating. Despite the major earnings-estimate increases, the unchanged rating suggests the analyst sees the improved outlook as largely reflected in the share price. Astera Labs recently reported revenue growth of 104.5% year over year and earnings above consensus, but its price-to-earnings ratio remains above 150.
• Neutral Sentiment: Reported short-interest data showed no meaningful positioning. The latest report listed short interest at zero shares and a zero-day short ratio, although the stated percentage change was unavailable, limiting its usefulness as a trading signal.
• Negative Sentiment: A director sold a substantial portion of his holdings. Stefan A. Dyckerhoff sold 12,499 shares for approximately $3.9 million, reducing his positions. The sales were made under a pre-arranged Rule 10b5-1 plan, which lessens—but does not eliminate—the potential bearish interpretation.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.